BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2022 10:52:23 AM | Browse: 295 | Download: 360
 |
Received |
|
2021-04-17 18:36 |
|
Peer-Review Started |
|
2021-04-17 18:38 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-27 02:24 |
|
Revised |
|
2021-08-07 17:30 |
|
Second Decision |
|
2022-03-22 06:26 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-03-27 06:45 |
|
Articles in Press |
|
2022-03-27 06:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-03-31 06:53 |
|
Publish the Manuscript Online |
|
2022-04-22 10:52 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Evidence Review |
| Article Title |
Evidence-based approach to management of hepatic encephalopathy in adults
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Gilles Jadd Hoilat, Fathima Keshia Suhail, Talal Adhami and Savio John |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gilles Jadd Hoilat, MBBS, Academic Fellow, Department of Medicine, SUNY Upstate Medical University, 750 E Adams St, Syracuse, NY 13210, United States. hoilatg@upstate.edu |
| Key Words |
Hepatic encephalopathy; Lactulose; Rifaximin; Fecal microbiota transplant; Zinc; L-ornithine L-aspartate |
| Core Tip |
Hepatic encephalopathy (HE) is a reversible syndrome of impaired brain function and represents one of the many complications of portal hypertension and decompensated liver disease. This review provides an update on the conventional and emerging treatment options for HE. The different conventional and emerging therapeutic options available to date are detailed in the manuscript. We have elaborated all the data available in the literature about the use of fecal microbiota transplant in the treatment of HE. |
| Publish Date |
2022-04-22 10:52 |
| Citation |
Hoilat GJ, Suhail FK, Adhami T, John S. Evidence-based approach to management of hepatic encephalopathy in adults. World J Hepatol 2022; 14(4): 670-681 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i4/670.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i4.670 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
